Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

17th Nov 2025 07:00

RNS Number : 6870H
CVS Group plc
17 November 2025
 

17 November 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 14 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

14/11/2025

Aggregate number of Ordinary Shares purchased:

26,396

Lowest price paid per share (GBp):

1,128.00

Highest price paid per share (GBp):

1,148.00

Volume weighted average price paid per share (GBp):

1,136.24

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,316,491 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 71,316,491 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 424,292 Ordinary Shares in aggregate at a weighted average price of 1,244.89 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

215

1134

14/11/2025 08:00:40

1332909357140974

XLON

273

1130

14/11/2025 08:03:45

1332909357142614

XLON

86

1128

14/11/2025 08:08:32

1332909357144639

XLON

13

1128

14/11/2025 08:08:32

1332909357144640

XLON

85

1128

14/11/2025 08:08:42

1332909357144672

XLON

76

1128

14/11/2025 08:15:52

1332909357147470

XLON

444

1132

14/11/2025 08:26:10

1332909357149407

XLON

76

1132

14/11/2025 08:31:28

1332909357150332

XLON

376

1134

14/11/2025 08:44:55

1332909357153622

XLON

422

1134

14/11/2025 08:44:55

1332909357153623

XLON

80

1134

14/11/2025 08:45:38

1332909357153808

XLON

39

1132

14/11/2025 08:51:00

1332909357154736

XLON

805

1132

14/11/2025 08:51:00

1332909357154737

XLON

76

1132

14/11/2025 08:52:15

1332909357154866

XLON

743

1132

14/11/2025 09:01:35

1332909357156233

XLON

149

1132

14/11/2025 09:01:35

1332909357156234

XLON

275

1132

14/11/2025 09:09:23

1332909357157451

XLON

478

1132

14/11/2025 09:09:23

1332909357157452

XLON

1136

1136

14/11/2025 09:44:10

1332909357162081

XLON

712

1136

14/11/2025 09:44:10

1332909357162082

XLON

225

1136

14/11/2025 09:44:10

1332909357162083

XLON

136

1136

14/11/2025 09:59:59

1332909357163662

XLON

314

1134

14/11/2025 10:18:17

1332909357165692

XLON

198

1134

14/11/2025 10:18:17

1332909357165695

XLON

76

1132

14/11/2025 10:41:43

1332909357168657

XLON

348

1130

14/11/2025 11:00:12

1332909357170872

XLON

239

1130

14/11/2025 11:00:12

1332909357170873

XLON

952

1130

14/11/2025 11:21:51

1332909357173620

XLON

2

1130

14/11/2025 11:21:52

1332909357173629

XLON

658

1130

14/11/2025 11:42:02

1332909357175641

XLON

634

1130

14/11/2025 11:42:02

1332909357175642

XLON

17

1128

14/11/2025 11:42:19

1332909357175675

XLON

16

1128

14/11/2025 11:42:46

1332909357175729

XLON

608

1128

14/11/2025 11:47:09

1332909357176433

XLON

1212

1136

14/11/2025 12:53:43

1332909357183918

XLON

470

1136

14/11/2025 12:53:43

1332909357183920

XLON

252

1138

14/11/2025 12:58:49

1332909357184498

XLON

1300

1136

14/11/2025 13:10:47

1332909357185797

XLON

1308

1136

14/11/2025 13:10:47

1332909357185798

XLON

709

1138

14/11/2025 13:40:04

1332909357188584

XLON

1320

1140

14/11/2025 13:49:27

1332909357189886

XLON

968

1140

14/11/2025 13:49:29

1332909357189898

XLON

200

1148

14/11/2025 13:52:58

1332909357190417

XLON

982

1146

14/11/2025 13:54:32

1332909357190590

XLON

275

1146

14/11/2025 13:54:33

1332909357190591

XLON

76

1144

14/11/2025 13:57:33

1332909357190905

XLON

234

1144

14/11/2025 13:57:33

1332909357190906

XLON

341

1138

14/11/2025 14:10:15

1332909357192775

XLON

197

1138

14/11/2025 14:10:15

1332909357192777

XLON

268

1136

14/11/2025 14:26:40

1332909357194556

XLON

306

1136

14/11/2025 14:30:55

1332909357195586

XLON

100

1136

14/11/2025 14:30:55

1332909357195608

XLON

501

1136

14/11/2025 14:30:55

1332909357195609

XLON

1341

1138

14/11/2025 14:39:43

1332909357197915

XLON

622

1138

14/11/2025 14:39:43

1332909357197916

XLON

100

1138

14/11/2025 14:39:43

1332909357197917

XLON

68

1138

14/11/2025 14:39:43

1332909357197918

XLON

24

1138

14/11/2025 14:39:43

1332909357197919

XLON

784

1138

14/11/2025 14:40:04

1332909357198014

XLON

60

1138

14/11/2025 14:40:04

1332909357198015

XLON

360

1142

14/11/2025 15:07:18

1332909357204815

XLON

556

1144

14/11/2025 15:08:40

1332909357205115

XLON

480

1148

14/11/2025 15:18:38

1332909357207301

XLON

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) [email protected]

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGGPGUPAGBC

Related Shares:

CVS Group
FTSE 100 Latest
Value9,515.06
Change-37.24